Intravitreal bevacizumab for neovascular glaucoma

Acta Clinica Croatica

Volumn 47, Issue 3, 2008, Pages 175-179

  Andrijević Derk, Biljana ^a   Vatavuk, Zoran ^a   Benčić, Goran ^a   Novak Lauš, Katia ^a   Mandić, Zdravko ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Glaucoma, neovascular therapy; Neovascularization drug therapy; Neovascularization pathology

Indexed keywords

BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BIOMICROSCOPY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GONIOSCOPY; HUMAN; INTRAOCULAR PRESSURE; MALE; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); PREOPERATIVE TREATMENT; REMISSION; TONOMETRY; VISUAL ACUITY; VITRECTOMY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; GLAUCOMA, NEOVASCULAR; HUMANS; INJECTIONS; MALE; MIDDLE AGED; VITREOUS BODY;

EID: 58149375666     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. AL-ASWAD L. Another role for Avastin in neovascular glaucoma. Rev Ophthalmol 2006;13:06.
2. AL-ASWAD L. Anti-VEGF drugs and neovascular glaucoma. Rev Ophthalmol 2007;14:03.
3. AIELLO LP, AVERY RL, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7.
4. ILJEV ME, DOMIG D, WOLF-SCHNURRBURSCH U, WOLF S, SARRA GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006;142:1054-6.
5. GIANSANTI F, VIRGILI G, BINI A, RAPIZZI E, GIACOMELLI G, DONATI MC, et al. Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study. Eur J Ophthalmol 2007;17:230-7.
6. AVERY RL, PIERAMICI D, RABENA M, et al. Intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-72.
7. AREVALO JF, FROMOW-GUERRA J, QUIROZ-MERCADO H, SANCHEZ JG, WU L, MAIA M, et al.; Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 2007;114:743-50.
8. AVERY R, PEARLMAN J, PIERAMICI DJ, RABENA MD, CASTELLARIN AA, NASIR MA, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695-705.
9. VATAVUK Z, BENČIĆ G, MANDIĆ Z. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol 2007;17:1-6.
10. JONAS JB, SPANDAU UH, SCHLICHTENBREDE F. Intravitreal bevacizumab for filtering surgery. Ophthalmic Res 2007;39:121-2.
11. SHAH PK, NARENDRAN V, TAWANSY KA, RAGHURAM A, NARENDRAN K. Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian J Ophthalmol 2007;55:75-6.